flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Patients with type 2 #diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with would mitigate these risks is unknown. Top Stories in Nephrology 2024
Description
Studies on needle phobia show that patients who know what to expect and understand the mechanism report significantly less discomfort than those who are uncertain
Even simple adjustments like understanding alcohol interactions and the role of B12 supplementation can optimize the treatment experience
thus, making it easier to stick to a healthy routine
These medications work with your bodys natural hormones to help regulate appetite, blood sugar, and digestion
Semaglutide stimulates receptors in your brain that affect your hunger and desire to eat, letting you eat fewer calories without feeling hungry
PLoS Comput Biol (2012) 8(9):e1002687
